European journal of clinical nutrition · 2026
Vitamin B12 absorption and factors associated with the response to long-term oral B12 supplementation: a secondary analysis of data from a B12-deficient Indian rural community.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yajnik Chittaranjan S, Deshmukh Urmila S, Bhat Dattatray S, Wagh Rucha Sh, Deshmukh Onkar A, Ladkat Rasika, Plank Lindsay D, Bandyopadhyay Souvik, Fall Caroline H, Refsum Helga, Rush Elaine C
Аннотация
BACKGROUND: The absorption of oral vitamin B12 (B-12) and predictors of its long-term supplementation are not well understood in populations with B-12 insufficiency.
OBJECTIVE: In a secondary data analysis of a B-12 absorption study and a supplementation trial in a B-12 insufficient rural Indian community, we examined (i) the distribution of plasma holotranscobalamin (holoTC) responses during an absorption test, and (ii) predictors of B-12 status during long-term, oral supplementation with physiological and near-physiological doses of B-12.
METHODS: Participants in the Pune Maternal Nutrition Study first underwent a B-12 absorption study (CobaSorb protocol) and subsequently participated in a 12-month double-blind randomized controlled trial of daily oral B-12 (0, 2, or 10 µg cyanocobalamin) and folic acid (0 or 200 µg). Plasma holoTC responses during absorption test were characterized, and linear mixed-effects models used to identify predictors of B-12 absorption and response during long-term supplementation.
RESULTS: Participants (313) included children (n = 109, mean age 9 y, weight 21.9 kg, BMI 13.6 kg/m2), mothers (n = 108, 30 y, 47.7 kg, 19.3 kg/m2), and fathers (n = 96, 37 y, 59.3 kg, 21.4 kg/m2). The holoTC response during the absorption test was positively associated with the B-12 dose (10 or 2 µg) and negatively with body weight. Improvements in B-12 status (plasma B-12, tHcy, combined B-12 indicator: 2cB12) after supplementation were positively predicted by baseline biomarker concentration, holoTC response during absorption test, B-12 dose, and compliance.
CONCLUSIONS: The holoTC response during B-12 absorption test predicted subsequent biomarker responses to long-term B-12 supplementation, linking absorptive capacity with metabolic correction. These findings provide a mechanistic framework for understanding variability in response to oral B-12 replenishment.
OBJECTIVE: In a secondary data analysis of a B-12 absorption study and a supplementation trial in a B-12 insufficient rural Indian community, we examined (i) the distribution of plasma holotranscobalamin (holoTC) responses during an absorption test, and (ii) predictors of B-12 status during long-term, oral supplementation with physiological and near-physiological doses of B-12.
METHODS: Participants in the Pune Maternal Nutrition Study first underwent a B-12 absorption study (CobaSorb protocol) and subsequently participated in a 12-month double-blind randomized controlled trial of daily oral B-12 (0, 2, or 10 µg cyanocobalamin) and folic acid (0 or 200 µg). Plasma holoTC responses during absorption test were characterized, and linear mixed-effects models used to identify predictors of B-12 absorption and response during long-term supplementation.
RESULTS: Participants (313) included children (n = 109, mean age 9 y, weight 21.9 kg, BMI 13.6 kg/m2), mothers (n = 108, 30 y, 47.7 kg, 19.3 kg/m2), and fathers (n = 96, 37 y, 59.3 kg, 21.4 kg/m2). The holoTC response during the absorption test was positively associated with the B-12 dose (10 or 2 µg) and negatively with body weight. Improvements in B-12 status (plasma B-12, tHcy, combined B-12 indicator: 2cB12) after supplementation were positively predicted by baseline biomarker concentration, holoTC response during absorption test, B-12 dose, and compliance.
CONCLUSIONS: The holoTC response during B-12 absorption test predicted subsequent biomarker responses to long-term B-12 supplementation, linking absorptive capacity with metabolic correction. These findings provide a mechanistic framework for understanding variability in response to oral B-12 replenishment.